{"Background": [106, 1476, 0, 2619, 5537, 0], "Results": [1477, 2223, 0], "Conclusion": [2224, 2618, 0], "Structure and life cycle": [7134, 9412, 0], "Pathogenesis and clinical course": [9413, 10950, 0], "Potential drug targets": [10951, 12419, 0], "SARS-COV-2": [5538, 12419, 1], "Chloroquine and hydroxychloroquine with or without azithromycin": [12470, 29369, 0], "Lopinavir/ritonavir": [29370, 37108, 0], "Remdesivir": [37109, 46318, 0], "Pharmacological agents with antiviral properties": [12420, 46318, 1], "Tocilizumab": [46376, 53203, 0], "Corticosteroids": [53204, 62156, 0], "Pharmacological agents with immunomodulatory properties": [46319, 62156, 1], "Anticoagulation": [62190, 67922, 0], "Adjunctive treatment strategies": [62157, 67922, 1], "Discussion": [67923, 75965, 0], "Conclusions": [75966, 77009, 0]}